How do you approach the decision to start clozapine in an inpatient setting when outpatient follow-up resources are limited or the patient’s ability to engage in follow-up is uncertain?  

The initiation of clozapine in inpatient settings is often limited by the need for ongoing monitoring and care coordination after discharge. In your practice, how do you navigate these challenges? Are there particular criteria, safeguards, or collaborative models you use to determine whether clozapine can be safely initiated when post-discharge follow-up is uncertain?